This is the mainstay of synovial sarcoma treatment .
Is curative in approximately 20 -- 70 % of patients , depending on the particular study being quoted .
This is the mainstay of synovial sarcoma treatment and is curative in approximately 20 -- 70 % of patients , depending on the particular study being quoted .